Moderated by Becca Wolsky (US) and Ian Hagemann (US)
The presenters and articles were:
Sam Amofa-Ho (US) presenting: Matulonis UA et al. Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study. J Clin Oncol. 2023 Jan 30. Epub ahead of print. PMID: 36716407.
Diana Jaravaza (SA) presenting: Coppock JD et al. PRAME Expression in Endometrioid and Serous Endometrial Carcinoma: A Potential Immunotherapeutic Target and Possible Diagnostic Pitfall. Int J Gynecol Pathol. 2023 Jan 1;42(1):35-42. PMID: 35512215.
Rodrigo Tavares Macedo (US) presenting: Chapel DB et al. A novel morphology-based risk stratification model for stage I uterine leiomyosarcoma: an analysis of 203 cases. Mod Pathol. 2022 Jun;35(6):794-807. PMID: 35121810.
